睿昂基因
(688217)
| 流通市值：9.69亿 | | | 总市值：14.44亿 |
| 流通股本：3750.45万 | | | 总股本：5585.59万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 64,188,221.36 | 258,211,314.47 | 198,819,318.04 | 127,566,392.52 |
| 营业收入 | 64,188,221.36 | 258,211,314.47 | 198,819,318.04 | 127,566,392.52 |
| 二、营业总成本 | 64,568,301.8 | 258,370,252.57 | 188,552,873.91 | 120,132,943.43 |
| 营业成本 | 14,347,851.26 | 69,173,437.28 | 49,633,598.61 | 35,343,584.2 |
| 税金及附加 | 568,292.86 | 2,205,475.45 | 1,560,252.87 | 960,811.6 |
| 销售费用 | 20,880,042.14 | 77,976,550.72 | 53,716,187.99 | 34,190,634.36 |
| 管理费用 | 13,096,212.42 | 42,924,631.59 | 36,846,537.7 | 20,853,142.99 |
| 研发费用 | 16,398,202.66 | 69,799,334.81 | 50,370,816.26 | 31,327,640.79 |
| 财务费用 | -722,299.54 | -3,709,177.28 | -3,574,519.52 | -2,542,870.51 |
| 其中:利息费用 | - | 828,478.71 | - | 292,792.23 |
| 其中:利息收入 | - | 3,809,912.74 | - | 1,040,806.31 |
| 加:公允价值变动收益 | -255,220.49 | 330,933.79 | 365,900.86 | -72,716.67 |
| 加:投资收益 | 409,122.19 | 2,680,346.22 | 1,851,211.97 | 1,524,509.87 |
| 资产处置收益 | 82,070.89 | 838,806.27 | 464,723.14 | 472,756.09 |
| 资产减值损失(新) | 322.84 | -8,883,190.79 | -559,540.71 | -587,338.31 |
| 信用减值损失(新) | -2,851,284.76 | -5,516,423.36 | -1,676,775.3 | -206,637.25 |
| 其他收益 | 781,246.63 | 4,220,387.35 | 1,082,543.2 | 700,137.41 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -2,213,823.14 | -6,488,078.62 | 11,794,507.29 | 9,264,160.23 |
| 加:营业外收入 | 330,662.48 | 192,811.12 | 94,330.02 | 3.47 |
| 减:营业外支出 | 61,130.05 | 3,105,478.22 | 2,570,248.53 | 2,151,750.89 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -1,944,290.71 | -9,400,745.72 | 9,318,588.78 | 7,112,412.81 |
| 减:所得税费用 | -506,937.02 | -4,595,913.49 | -1,750,148.5 | -1,133,708.76 |
| 六、净利润 | -1,437,353.69 | -4,804,832.23 | 11,068,737.28 | 8,246,121.57 |
| 持续经营净利润 | -1,437,353.69 | -4,804,832.23 | 11,068,737.28 | 8,246,121.57 |
| 归属于母公司股东的净利润 | 533,165.07 | 7,930,692.32 | 18,829,092.35 | 16,235,537.23 |
| 少数股东损益 | -1,970,518.76 | -12,735,524.55 | -7,760,355.07 | -7,989,415.66 |
| (一)基本每股收益 | 0.01 | 0.14 | 0.34 | 0.29 |
| (二)稀释每股收益 | 0.01 | 0.14 | 0.34 | 0.29 |
| 九、综合收益总额 | -1,437,353.69 | -4,804,832.23 | 11,068,737.28 | 8,246,121.57 |
| 归属于母公司股东的综合收益总额 | 533,165.07 | 7,930,692.32 | 18,829,092.35 | 16,235,537.23 |
| 归属于少数股东的综合收益总额 | -1,970,518.76 | -12,735,524.55 | -7,760,355.07 | -7,989,415.66 |
| 公告日期 | 2024-04-27 | 2024-04-17 | 2023-10-27 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |